239 related articles for article (PubMed ID: 20613638)
1. HIV-1 gp120-induced injury to the blood-brain barrier: role of metalloproteinases 2 and 9 and relationship to oxidative stress.
Louboutin JP; Agrawal L; Reyes BA; Van Bockstaele EJ; Strayer DS
J Neuropathol Exp Neurol; 2010 Aug; 69(8):801-16. PubMed ID: 20613638
[TBL] [Abstract][Full Text] [Related]
2. Blood-brain barrier abnormalities caused by HIV-1 gp120: mechanistic and therapeutic implications.
Louboutin JP; Strayer DS
ScientificWorldJournal; 2012; 2012():482575. PubMed ID: 22448134
[TBL] [Abstract][Full Text] [Related]
3. HIV-1 gp120 upregulates matrix metalloproteinases and their inhibitors in a rat model of HIV encephalopathy.
Louboutin JP; Reyes BA; Agrawal L; Van Bockstaele EJ; Strayer DS
Eur J Neurosci; 2011 Dec; 34(12):2015-23. PubMed ID: 22092673
[TBL] [Abstract][Full Text] [Related]
4. Blood-brain barrier abnormalities caused by exposure to HIV-1 gp120--protection by gene delivery of antioxidant enzymes.
Louboutin JP; Reyes BA; Agrawal L; Maxwell CR; Van Bockstaele EJ; Strayer DS
Neurobiol Dis; 2010 May; 38(2):313-25. PubMed ID: 20219678
[TBL] [Abstract][Full Text] [Related]
5. Antioxidant enzyme gene delivery to protect from HIV-1 gp120-induced neuronal apoptosis.
Agrawal L; Louboutin JP; Reyes BA; Van Bockstaele EJ; Strayer DS
Gene Ther; 2006 Dec; 13(23):1645-56. PubMed ID: 16871233
[TBL] [Abstract][Full Text] [Related]
6. HIV-1 gp120-induced neuroinflammation: relationship to neuron loss and protection by rSV40-delivered antioxidant enzymes.
Louboutin JP; Reyes BA; Agrawal L; Van Bockstaele EJ; Strayer DS
Exp Neurol; 2010 Jan; 221(1):231-45. PubMed ID: 19913017
[TBL] [Abstract][Full Text] [Related]
7. Protecting neurons from HIV-1 gp120-induced oxidant stress using both localized intracerebral and generalized intraventricular administration of antioxidant enzymes delivered by SV40-derived vectors.
Louboutin JP; Agrawal L; Reyes BA; Van Bockstaele EJ; Strayer DS
Gene Ther; 2007 Dec; 14(23):1650-61. PubMed ID: 17914406
[TBL] [Abstract][Full Text] [Related]
8. A rat model of human immunodeficiency virus 1 encephalopathy using envelope glycoprotein gp120 expression delivered by SV40 vectors.
Louboutin JP; Agrawal L; Reyes BA; Van Bockstaele EJ; Strayer DS
J Neuropathol Exp Neurol; 2009 May; 68(5):456-73. PubMed ID: 19525894
[TBL] [Abstract][Full Text] [Related]
9. Hemoglobin-induced oxidative stress contributes to matrix metalloproteinase activation and blood-brain barrier dysfunction in vivo.
Katsu M; Niizuma K; Yoshioka H; Okami N; Sakata H; Chan PH
J Cereb Blood Flow Metab; 2010 Dec; 30(12):1939-50. PubMed ID: 20354546
[TBL] [Abstract][Full Text] [Related]
10. Gene delivery of antioxidant enzymes inhibits human immunodeficiency virus type 1 gp120-induced expression of caspases.
Louboutin JP; Agrawal L; Reyes BA; van Bockstaele EJ; Strayer DS
Neuroscience; 2012 Jul; 214():68-77. PubMed ID: 22531373
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 gp120 neurotoxicity proximally and at a distance from the point of exposure: protection by rSV40 delivery of antioxidant enzymes.
Louboutin JP; Agrawal L; Reyes BA; Van Bockstaele EJ; Strayer DS
Neurobiol Dis; 2009 Jun; 34(3):462-76. PubMed ID: 19327399
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat.
Yang Y; Estrada EY; Thompson JF; Liu W; Rosenberg GA
J Cereb Blood Flow Metab; 2007 Apr; 27(4):697-709. PubMed ID: 16850029
[TBL] [Abstract][Full Text] [Related]
13. Neurodegeneration in striatum induced by the mitochondrial toxin 3-nitropropionic acid: role of matrix metalloproteinase-9 in early blood-brain barrier disruption?
Kim GW; Gasche Y; Grzeschik S; Copin JC; Maier CM; Chan PH
J Neurosci; 2003 Sep; 23(25):8733-42. PubMed ID: 14507973
[TBL] [Abstract][Full Text] [Related]
14. Induction of mmp-9 expression and endothelial injury by oxidative stress after spinal cord injury.
Yu F; Kamada H; Niizuma K; Endo H; Chan PH
J Neurotrauma; 2008 Mar; 25(3):184-95. PubMed ID: 18352832
[TBL] [Abstract][Full Text] [Related]
15. Increased blood-brain barrier permeability and altered tight junctions in experimental diabetes in the rat: contribution of hyperglycaemia and matrix metalloproteinases.
Hawkins BT; Lundeen TF; Norwood KM; Brooks HL; Egleton RD
Diabetologia; 2007 Jan; 50(1):202-11. PubMed ID: 17143608
[TBL] [Abstract][Full Text] [Related]
16. Methamphetamine alters blood brain barrier permeability via the modulation of tight junction expression: Implication for HIV-1 neuropathogenesis in the context of drug abuse.
Mahajan SD; Aalinkeel R; Sykes DE; Reynolds JL; Bindukumar B; Adal A; Qi M; Toh J; Xu G; Prasad PN; Schwartz SA
Brain Res; 2008 Apr; 1203():133-48. PubMed ID: 18329007
[TBL] [Abstract][Full Text] [Related]
17. Influence of hyperglycemia on oxidative stress and matrix metalloproteinase-9 activation after focal cerebral ischemia/reperfusion in rats: relation to blood-brain barrier dysfunction.
Kamada H; Yu F; Nito C; Chan PH
Stroke; 2007 Mar; 38(3):1044-9. PubMed ID: 17272778
[TBL] [Abstract][Full Text] [Related]
18. Dopaminergic neurotoxicity of HIV-1 gp120: reactive oxygen species as signaling intermediates.
Agrawal L; Louboutin JP; Marusich E; Reyes BA; Van Bockstaele EJ; Strayer DS
Brain Res; 2010 Jan; 1306():116-30. PubMed ID: 19815008
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 gp120 compromises blood-brain barrier integrity and enhances monocyte migration across blood-brain barrier: implication for viral neuropathogenesis.
Kanmogne GD; Schall K; Leibhart J; Knipe B; Gendelman HE; Persidsky Y
J Cereb Blood Flow Metab; 2007 Jan; 27(1):123-34. PubMed ID: 16685256
[TBL] [Abstract][Full Text] [Related]
20. HIV-1 viral proteins gp120 and Tat induce oxidative stress in brain endothelial cells.
Price TO; Ercal N; Nakaoke R; Banks WA
Brain Res; 2005 May; 1045(1-2):57-63. PubMed ID: 15910762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
